Literature DB >> 6181359

Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis.

D C Dumonde, E Kasp-Grochowska, E Graham, M D Sanders, J P Faure, Y de Kozak, V van Tuyen.   

Abstract

Sera from 44 patients with isolated retinal vasculitis (RV), 38 patients with retinal vasculitis accompanying systemic inflammatory diseases (RV + SID), and 33 patients with a similar range of systemic inflammatory diseases without eye involvement (SID alone) were assayed for circulating immune complexes (CIC) and for anti-retinal autoantibodies. CIC were present in 41% of patients with isolated RV and 55% of patients with RV + SID, whilst anti-retinal antibodies were present in about 70% of all patients with RV. 42% of those with SID alone had CIC and 30% of those with SID alone had retinal autoantibodies. Titres of anti-retinal antibodies were higher in patients with RV than in those with SID alone. In isolated RV there was an inverse relation between pronounced retinal autoimmunity and the occurrence of CIC--i.e., the more severe autoimmune retinal disease occurred in CIC-negative patients. Most patients with RV + SID tended to have mild or moderate retinal disease accompanied by both retinal autoantibodies and CIC, but severe retinal disease occurred in CIC-positive patients who did not have circulating anti-retinal antibodies. Patients with SID alone had high titres of retinal antibodies only when they were CIC-positive. It is suggested that the formation of CIC, possibly of an idiotype/anti-idiotype nature, may be a compensatory mechanism accompanying anti-retinal autoimmunity and that an imbalance between autoimmunity and immune complex formation may be an important predisposing factor in the development of retinal inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181359     DOI: 10.1016/s0140-6736(82)92679-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

1.  Electroretinography and electro-oculography to localize abnormalities in early-stage inflammatory eye disease.

Authors:  H Ikeda; A Franchi; G Turner; J Shilling; E Graham
Journal:  Doc Ophthalmol       Date:  1989-12       Impact factor: 2.379

Review 2.  Endogenous posterior uveitis.

Authors:  J V Forrester
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

3.  Circulating immune complexes may play a regulatory and pathogenic role in experimental autoimmune uveoretinitis.

Authors:  E Kasp; M R Stanford; E Brown; A G Coombes; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

4.  Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations.

Authors:  J R Heckenlively; N Aptsiauri; S Nusinowitz; C Peng; P A Hargrave
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 5.  Circulating immune complexes in uveitis patients.

Authors:  H A Hylkema; A Kijlstra
Journal:  Int Ophthalmol       Date:  1989-07       Impact factor: 2.031

6.  Morphometric analysis of T lymphocyte compartmentation in experimental autoimmune uveoretinitis.

Authors:  E C Brown; E Kasp; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

7.  Autoantibodies to retinal astrocytes associated with age-related macular degeneration.

Authors:  P L Penfold; J M Provis; J H Furby; P A Gatenby; F A Billson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

8.  Idiotypic expression of antibodies to retinal S-antigen in experimental autoimmune uveoretinitis.

Authors:  S Suleyman; D C Dumonde; J P Banga
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

9.  Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings.

Authors:  J R Heckenlively; A M Solish; S M Chant; R H Meyers-Elliott
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

10.  Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.

Authors:  M Stanford; T Whittall; L A Bergmeier; M Lindblad; S Lundin; T Shinnick; Y Mizushima; J Holmgren; T Lehner
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.